Tag: Actinic Keratosis

Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study

Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study

| March 1, 2019

 J Clin Aesthet Dermatol. 2019;12(3):32–38 by Mark S. Nestor, MD, PhD; Brian Berman, MD, PhD; Jigesh Patel, BS; and Alec Lawson Drs. Nestor and Berman and Messrs. Patel and Lawson are with the Center for Clinical and Cosmetic Research in Aventura, Florida. Drs. Nestor and Berman are also with the Department of Dermatology and Cutaneous […]

Continue Reading

Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients

Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients

| September 1, 2018

J Clin Aesthet Dermatol. 2018;11(9):28–31 by James Del Rosso, DO; Neil Swanson, MD; Brian Berman, MD, PhD; George M. Martin, MD; Tina Lin, PharmD; and Ted Rosen, MD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada. Dr. Swanson is with the Department of Dermatology at Oregon Health and Science University […]

Continue Reading

Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial

Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial

| December 1, 2017

by Daniel M. Siegel, MD; Stephen Tyring, MD, PhD; Walter K. Nahm, MD, PhD; Marie Louise Østerdal, MSc; Astrid H. Petersen, PhD;  and Brian Berman, MD, PhD Dr. Siegel is with Long Island Skin Cancer and Dermatologic Surgery in New York, New York. Dr. Tyring is with the Center for Clinical Studies in Houston, Texas. […]

Continue Reading

Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial

Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial

| November 1, 2017

by Brian Berman, MD, PhD; Stephen Tyring, MD, PhD; Walter K. Nahm, MD, PhD; Marie Louise Østerdal, MSc; Astrid H. Petersen, PhD; and Daniel M. Siegel, MD Dr. Berman is Co-Director at Center for Clinical and Cosmetic Research in Aventura, Florida. Dr. Tyring is Medical Director at the Center for Clinical Studies at University of […]

Continue Reading

Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015%

Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015%

| October 1, 2017

by Orit Markowitz, MD; Katie Wang, DO; Amanda Levine, MD; Michelle Schwartz, BA;  Sumeet Minhas, BA; Eleanor Feldman, BA; and Daniel M. Siegel, MD Drs. Markowitz, Wang, Levine; Ms. Minhas; and Ms. Schwartz and Ms. Feldman are associated with the Department of Dermatology, SUNY Downstate Medical Center, New York, New York; the Department of Dermatology, […]

Continue Reading

A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest

A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest

| August 1, 2017

by Douglas C. Wu, MD, PhD; Isabella Guiha, BSc; and Mitchel P. Goldman, MD Drs. Wu and Goldman and Ms. Guiha are with Cosmetic Laser Dermatology, San Diego, California. J Clin Aesthet Dermatol. 2017;10(8):31–36 Funding: This study was sponsored and funded by LEO Pharma. Disclosures: The authors have no conflicts of interest relevant to the […]

Continue Reading

The Impact of the Current United States Guidelines on the Management of Actinic Keratosis: Is It Time for an Update?

The Impact of the Current United States Guidelines on the Management of Actinic Keratosis: Is It Time for an Update?

| November 5, 2010 | 0 Comments

George Martin, MD Dermatology and Laser Center of Maui, Kihei, Hawaii

Continue Reading